Finance

Lists
300357:SHE
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
CNÂ¥19.06
+1.01%
(+0.19) 1D
Oct 19, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300357...
Open
CNÂ¥18.68
High
CNÂ¥19.15
Low
CNÂ¥18.68
Mkt. cap
9.88B
Avg. vol.
8.64M
Volume
3.68M
Dividend
1.31%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Jul 9, 2026
P/E ratio
23.91
52-wk high
CNÂ¥35.84
52-wk low
CNÂ¥18.65
EPS
CNÂ¥0.80
Shares outstanding
523.58M
No. of employees
2K
Open
CNÂ¥18.68
High
CNÂ¥19.15
Low
CNÂ¥18.68
Mkt. cap
9.88B
Avg. vol.
8.64M
Volume
3.68M
Dividend
1.31%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Jul 9, 2026
P/E ratio
23.91
52-wk high
CNÂ¥35.84
52-wk low
CNÂ¥18.65
EPS
CNÂ¥0.80
Shares outstanding
523.58M
No. of employees
2K
News stories
From web sources and news partners
About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
CEO-
Employees1.81K
FoundedSep 19, 2002
Headquarters-
SectorPharmaceutical industry
Websitewolwobiotech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
369.12M
209.04M
252.84M
261.32M
Cost of goods sold
15.75M
11.11M
12.02M
12.18M
Cost of revenue
15.75M
11.11M
12.02M
12.18M
Research and development expenses
26.87M
31.40M
24.91M
22.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
134.52M
128.79M
117.09M
118.40M
Operating expense
166.35M
160.79M
143.93M
143.60M
Total operating expenses
182.11M
171.90M
155.95M
155.79M
Operating income
187.02M
37.15M
96.89M
105.54M
Other non operating income
160.14K
-246.72K
-24.48K
-175.66K
EBT including unusual items
194.75M
38.43M
131.78M
108.66M
EBT excluding unusual items
194.31M
41.38M
131.03M
109.00M
Income tax expense
29.94M
5.57M
15.27M
16.59M
Effective tax rate
15.37%
14.51%
11.59%
15.27%
Other operating expenses
972.53K
5.99M
-2.31M
3.23M
Net income
167.86M
36.07M
119.23M
94.22M
Net profit margin
45.47%
17.26%
47.16%
36.05%
Earnings per share
-
-
-
-
Interest and investment income
7.32M
4.67M
34.39M
3.81M
Interest expense
-190.02K
-196.48K
-233.08K
-172.40K
Net interest expenses
7.13M
4.48M
34.16M
3.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
197.88M
49.60M
109.35M
119.27M
Gain or loss from assets sale
630.07K
-630.07K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps